A hidden immune signature may quietly determine who develops side effects from Alzheimer’s therapy. Scientists at the University of Kentucky have uncovered a biological signal that may help explain one of the most concerning side effects tied to new Alzheimer’s treatments. Their findings suggest that a simple blood test could one day identify which patients [...]from SciTechDaily https://ift.tt/9iw3PXy
